The Journal of Organic Chemistry
Article
(101 MHz, CDCl3): δ = 135.3, 134.9, 134.2, 128.8, 127.4, 127.3,
127.2, 126.0, 125.8, 122.2, 119.4, 117.3, 116.7, 110.7, 72.2, 68.9, 46.6;
mg, 0.88 μL, 0.01 mmol) in THF (0.16 M) by general procedure A
for catalysis. The crude product was purified by column
chromatography (12 g SiO2, static elution, n-hexane/ethyl acetate
95:5) and obtained as colorless oil: 45 mg, 0.15 mmol, 62%, d.r. >
20:1 (computed from 1H−1H NOESY data). The spectral data
matches with the one reported in the literature.5 1H NMR (400 MHz,
CDCl3): δ = 7.47−7.39 (m, 3H), 7.36−7.29 (m, 2H), 7.28−7.21 (m,
2H), 7.18−7.11 (m, 1H), 7.08−7.00 (m, 1H), 5.10 (dd, J = 5.8, 2.7
Hz, 1H), 4.87 (dd, J = 10.7, 2.8 Hz, 2H), 4.62 (dd, J = 10.5, 3.0 Hz,
1H), 3.63 (s, 3H), 3.04−2.92 (m, 1H), 2.90−2.77 (m, 1H), 2.22−
2.06 (m, 1H), 1.99−1.86 (m, 1H), 0.92 (t, J = 7.3 Hz, 3H). Note:
The chemical shift displayed in bold above refers to the minor
diastereomer; 13C{1H} NMR (101 MHz, CDCl3): δ = 142.8, 137.7,
135.6, 128.3, 127.4, 126.3, 125.9, 121.3, 119.2, 118.0, 109.3, 108.8,
76.6, 74.0, 31.0, 30.8, 28.1, 8.6.
9-Benzyl-6-bromo-1-ethyl-1,3,4,9-tetrahydropyrano[3,4-b]-
indole (5ad). The compound 5ad was synthesized from 3-(2-
(allyloxy)ethyl)-1-benzyl-5-bromo-1H-indole (0.25 mmol, 92.5 mg)
using [(Me3P)4NiH]N(SO2CF3)2 (1.6 mg, 2.48 μmol), TfOH (1.5
mg, 0.88 μL, 0.01 mmol) in THF (0.16 M) by general procedure A
for catalysis. The crude product was purified by column
chromatography (12 g SiO2, static elution, n-hexane/ethyl acetate
95:5) and obtained as yellow oil: 61 mg, 0.16 mmol, 66%. The
spectral data matches with the one reported in the literature.5 1H
NMR (300 MHz, CDCl3): δ = 7.64 (d, J = 1.9 Hz, 1H), 7.30−7.14
(m, 4H), 7.01−6.88 (m, 3H), 5.29−5.10 (m, 2H), 4.73−4.64 (m,
1H), 4.15−4.01 (m, 1H), 3.91−3.79 (m, 1H), 2.86−2.73 (m, 1H),
1.88−1.61 (m, 2H), 0.95 (t, J = 7.3 Hz, 3H); 13C{1H} NMR (75
MHz, CDCl3): δ = 137.6, 136.9, 135.8, 128.8, 128.6, 127.5, 125.8,
124.2, 120.8, 112.7, 111.1, 107.7, 72.6, 61.1, 47.4, 27.0, 22.3, 9.8.
1-Ethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole (5ae). The
compound 5ae was synthesized from 3-(2-(allyloxy)ethyl)-1H-indole
(0.25 mmol, 50 mg) using [(Me3P)4NiH]N(SO2CF3)2 (1.6 mg, 2.48
μmol) and TfOH (1.5 mg, 0.88 μL, 0.01 mmol) in THF (0.16 M) by
general procedure A for catalysis. The crude product was purified by
column chromatography (12 g SiO2, static elution, n-hexane/ethyl
acetate 85:15) and obtained as yellow oil: 27 mg, 0.13 mmol, 53%.
The spectral data matches with the one reported in the literature.5 1H
NMR (300 MHz, CDCl3): δ = 7.65 (s, 1H), 7.48−7.37 (m, 1H),
7.29−7.20 (m, 1H), 7.13−6.98 (m, 2H), 4.79−4.64 (m, 1H), 4.26−
4.13 (m, 1H), 3.82−3.67 (m, 1H), 2.96−2.78 (m, 1H), 2.70−2.56
(m, 1H), 1.95−1.65 (m, 2H), 0.97 (t, J = 7.4 Hz, 3H); 13C{1H} NMR
(75 MHz, CDCl3): δ = 135.8, 134.7, 127.2, 121.6, 119.6, 118.1, 110.8,
108.3, 73.8, 64.5, 27.5, 22.40, 9.3.
IR: ν = 2903, 2862, 2981, 1602, 1546, 1438, 1371, 1237, 1043, 1095,
̃
797, 760; HRMS (ESI) m/z [M + Na]+: calcd for C19H18ClNONa,
334.0969; found, 334.0971.
1-(3-(Allyloxy)propyl)-3-phenyl-1H-indole (3bf). Compound
3bf was synthesized from 3-(3-phenyl-1H-indol-1-yl)propan-1-ol
(778.4 mg, 3.1 mmol, 1 equiv) and allyl bromide (400 μL, 4.6
mmol, 1.5 equiv) following the general procedure AB for O-allylation,
purified by column chromatography n-hexane/ethyl acetate 9:1 and
isolated as yellow oil: 274.2 mg, 0.94 mmol, 30%. The spectral data
matches with the one reported in the literature.5 1H NMR (300 MHz,
CDCl3): δ = 7.94 (dd, J = 8.4, 1.4 Hz, 1H), 7.71−7.61 (m, 2H),
7.49−7.36 (m, 3H), 7.30−7.12 (m, 4H), 6.03−5.82 (m, 1H), 5.38−
5.14 (m, 2H), 4.30 (t, J = 6.7 Hz, 2H), 3.98−3.89 (m, 2H), 3.37 (t, J
= 5.8 Hz, 2H), 2.19−2.06 (m, 2H); 13C{1H} NMR (101 MHz,
CDCl3): δ = 137.0, 135.8, 134.8, 128.9, 127.4, 126.3, 126.0, 125.8,
122.0, 120.1, 120.0, 117.2, 116.9, 109.9, 72.1, 66.7, 43.1, 30.4.
1-(2-(Allyloxy)ethyl)-3-(phenylthio)-1H-indole (3bg). Com-
pound 3bg was synthesized from 2-(3-(phenylthio)-1H-indol-1-
yl)ethan-1-ol (680.1 mg, 2.5 mmol, 1 equiv) and allyl bromide
(328 μL, 3.79 mmol, 1.5 equiv) following the general procedure AB
for O-allylation, purified by column chromatography n-hexane/ethyl
1
acetate 9:1 and isolated as yellow oil: 539.3 mg, 1.74 mmol, 69%. H
NMR (400 MHz, CDCl3): δ = 7.62 (d, J = 8.0 Hz, 1H), 7.48 (s, 1H),
7.43 (d, J = 8.3 Hz, 1H), 7.26 (s, 1H), 7.21−7.11 (m, 3H), 7.14−7.07
(m, 2H), 7.09−7.00 (m, 1H), 5.89−5.75 (m, 1H), 5.25−5.10 (m,
2H), 4.36 (t, J = 5.5 Hz, 2H), 3.99−3.91 (m, 2H), 3.80 (t, J = 5.5 Hz,
2H); 13C{1H} NMR (101 MHz, CDCl3): δ = 139.6, 136.9, 134.9,
134.1, 129.9, 128.6, 125.7, 124.6, 122.5, 120.5, 119.8, 117.3, 109.8,
100.8, 72.2, 68.6, 46.6; IR ν = 3052, 2933, 2855, 1580,
(cm−1): ν
̃ ̃
1505, 1457, 1349, 1244, 1207, 1155, 1103, 991, 924, 734, 689; HRMS
(ESI) m/z [M + Na]+: calcd for C19H19NOSNa, 332.1080; found,
332.1079.
9-Benzyl-1-ethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole
(5aa). The compound 5aa was synthesized from 3-(2-(allyloxy)-
ethyl)-1-benzyl-1H-indole (72 mg, 0.25 mmol, 1 equiv) using
[(Me3P)4NiH]N(SO2CF3)2 (1.6 mg, 2.48 μmol), TfOH (1.5 mg,
0.88 μL, 0.01 mmol) and THF (1.5 mL) by general procedure A for
catalysis. The crude product was purified by column chromatography
(12 g SiO2, static elution, n-hexane/ethyl acetate 95:5) and obtained
as colorless oil: 57.6 mg, 0.19 mmol, 80%. The spectral data matches
with the one reported in the literature.5 1H NMR (300 MHz,
CDCl3): δ = 7.52 (dd, J = 5.7, 2.9 Hz, 1H), 7.28−7.17 (m, 3H),
7.14−7.06 (m, 3H), 6.98−6.92 (m, 2H), 5.33−5.09 (m, 2H), 4.74−
4.65 (m, 1H), 4.14−4.02 (m, 1H), 3.92−3.78 (m, 1H), 2.92−2.78
(m, 2H), 1.91−1.64 (m, 2H), 0.94 (t, J = 7.3 Hz, 3H); 13C{1H} NMR
(101 MHz, CDCl3): δ = 137.5, 137.2, 136.3, 128.8, 127.4, 126.9,
125.9, 121.6, 119.4, 118.1, 109.7, 108.1, 72.8, 61.3, 47.3, 27.1, 22.5,
9.8.
9-Benzyl-1-ethyl-1-methyl-1,3,4,9-tetrahydropyrano[3,4-b]-
indole (5af). The compound 5af was synthesized from 1-benzyl-3-
(2-(but-3-en-2-yloxy)ethyl)-1H-indole (0.25 mmol, 76.3 mg) using
the general procedure A for catalysis. Following changes were made to
the standard procedure. [(Me3P)4NiH]N(SO2CF3)2 (5 mol %,
0.0125 mmol, 8.0 mg), CH3SO3H (20 mol %, 3.2 μL, 0.049
mmol), THF (0.16 M). Following the initial 30 min of room
temperature stirring with the precatalyst, the reaction mixture was
heated to 60 °C (oil bath) for additional 30 min. The crude product
was purified by flash column chromatography on silica gel (12 g SiO2,
stepwise elution n-hexane/ethyl acetate 97:3 for 5 CV (column
volume) and then 95:5) and obtained as colorless oil: 34 mg, 0.11
9-Benzyl-1-ethyl-6-methoxy-1,3,4,9-tetrahydropyrano[3,4-
b]indole (5ab). Compound 5ab was synthesized from 3-(2-
(allyloxy)ethyl)-1-benzyl-5-methoxy-1H-indole (1.29 g, 4.0 mmol),
[(Me3P)4NiH]N(SO2CF3)2 (1.9 mg, 3.0 μmol), triflic acid (5 μL,
0.06 mmol) in THF (0.16 M) using general procedure A for catalysis.
The crude product obtained after work-up was purified by
recrystallization with n-hexane/ethyl acetate (20:3). The final product
was obtained as an off-white solid: 763 mg, 2.37 mmol, 59%, with
1
mmol, 44%. H NMR (400 MHz, CDCl3): δ = 7.51−7.44 (m, 1H),
7.22−7.10 (m, 3H), 7.07−6.94 (m, 3H), 6.84 (d, J = 9.1 Hz, 2H),
5.32 (s, 2H), 4.01−3.82 (m, 2H), 2.88−2.69 (m, 2H), 1.90 (dq, J =
14.7, 7.4 Hz, 1H), 1.69 (dq, J = 14.6, 7.3 Hz, 1H), 1.39 (s, 3H), 0.70
(t, J = 7.3 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3): δ = 138.9,
137.8, 137.0, 128.6, 127.1, 126.6, 125.6, 121.6, 119.4, 118.1, 110.0,
108.7, 75.2, 59.9, 48.0, 32.9, 25.2, 22.8, 7.9. IR: 2967, 2862, 2929,
1464, 1345, 1308, 1151, 1080, 907, 726, 697; HRMS (ESI) m/z
[M]+: calcd for C21H23NO, 305.1774; found, 305.1775.
1
>98% purity as determined by H NMR spectroscopy. The spectral
data matches with the one reported in the literature.5 1H NMR (400
MHz, CDCl3): δ = 7.23−7.14 (m, 4H), 6.96−6.86 (m, 4H), 6.70 (dd,
J = 8.8, 2.5 Hz, 1H), 5.13 (q, J = 17.2 Hz, 2H), 4.65−4.59 (m, 1H),
4.08−3.97 (m, 1H), 3.79 (s, 3H), 2.85−2.67 (m, 2H), 1.85−1.57 (m,
2H), 0.89 (t, J = 7.3 Hz, 3H); 13C{1H} NMR (75 MHz, CDCl3): δ =
154.1, 137.5, 137.0, 132.3, 128.7, 127.3, 127.2, 125.9, 111.2, 110.2,
107.6, 100.4, 72.8, 61.3, 55.9, 47.4, 27.1, 22.5, 9.8.
1-Ethyl-10-phenyl-3,4-dihydro-1H-[1,4]oxazino[4,3-a]-
indole (5ba). This compound 5ba was synthesized from 1-(2-
(allyloxy)ethyl)-3-phenyl-1H-indole (69.4 mg, 0.25 mmol) using
[(Me3P)4NiH]N(SO2CF3)2 (1.6 mg, 2.48 μmol), TfOH (1.5 mg,
0.88 μL, 0.01 mmol) in THF (0.16 M) following general procedure A
1-Ethyl-9-methyl-3-phenyl-1,3,4,9-tetrahydropyrano[3,4-
b]indole (5ac). The compound 5ac was synthesized from 3-(2-
(allyloxy)-2-phenylethyl)-1-methyl-1H-indole (0.25 mmol, 72.7 mg)
using [(Me3P)4NiH]N(SO2CF3)2 (1.6 mg, 2.48 μmol), TfOH (1.5
H
J. Org. Chem. XXXX, XXX, XXX−XXX